Masimo Corporation (MASI) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$178.49
Price Target
$187.50
Target Range
$180.00 — $200.00
Analyst Rating
Buy
Forward P/E32.5x
Trailing P/E-63.7x
Forward PEG—
Implied Growth+279.0%
Median Target$185.00
Analyst Spread10.7%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$180
+0.8%
Consensus
$188
+5.1%
Bull Case
$200
+12.1%
MASI Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Masimo Corporation (MASI) has a Wall Street consensus price target of $187.50, based on estimates from 23 covering analysts. With the stock currently trading at $178.49, this represents a potential upside of +5.1%. The company has a market capitalization of $9.35B.
Analyst price targets range from a low of $180.00 to a high of $200.00, representing a 11% spread in expectations. The median target of $185.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,9 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, MASI trades at a trailing P/E of -63.7x and forward P/E of 32.5x. Analysts expect EPS to grow +279.0% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+43.9%
Avg Forward P/E19.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 PODDInsulet Corporation | $10.6B | $151.17 | $339.00 | +124.3% | Buy | 23.8x | 50 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $79.00 | +3.9% | Hold | 17.2x | 42 |
 NVCRNovoCure Limited | $1.9B | $16.50 | $33.50 | +103.1% | Buy | — | 15 |
 ITGRInteger Holdings Corporation | $3.0B | $86.29 | $98.00 | +13.6% | Buy | 13.3x | 14 |
 ICUIICU Medical, Inc. | $3.0B | $119.59 | $163.50 | +36.7% | Buy | 14.8x | 11 |
 NTRANatera, Inc. | $29.6B | $215.09 | $262.50 | +22.0% | Buy | — | 27 |
 INVAInnoviva, Inc. | $1.9B | $22.52 | $37.67 | +67.3% | Buy | 11.8x | 10 |
 NOVTNovanta Inc. | $5.0B | $138.90 | $150.00 | +8.0% | Buy | 39.0x | 3 |
 MMSIMerit Medical Systems, Inc. | $3.7B | $61.63 | $95.00 | +54.1% | Buy | 15.3x | 13 |
 HAYWHayward Holdings, Inc. | $3.2B | $14.92 | $15.75 | +5.6% | Hold | 17.4x | 10 |
Upside Potential Comparison
PODDNVCRINVAMMSIICUINTRAITGRNOVTSee MASI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MASI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MASI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMASI — Frequently Asked Questions
Quick answers to the most common questions about buying MASI stock.
What is the MASI stock price target for 2026?
The consensus price target for MASI is $187.5, close to the current price of $178.485 (5.1% implied move). Based on 23 analyst estimates, the stock appears fairly valued near current levels.
Is MASI a buy, sell, or hold?
MASI has a consensus rating of "Buy" based on 23 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $187.5 implies 5.1% upside from current levels.
Is MASI stock overvalued or undervalued?
MASI trades at a forward P/E of 32.4613x, representing a moderate valuation. With analysts targeting $187.5 (5.1% implied move), the stock appears reasonably valued with upside.
How high can MASI stock go?
The most bullish Wall Street analyst has a price target of $200 for MASI, while the most conservative target is $180. The consensus of $187.5 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover MASI stock?
MASI is well covered by analysts, with 23 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 9 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the MASI stock forecast?
The 12-month MASI stock forecast based on 23 Wall Street analysts shows a consensus price target of $187.5, with estimates ranging from $180 (bear case) to $200 (bull case). The median consensus rating is "Buy".
What is MASI's forward P/E ratio?
MASI trades at a forward P/E ratio of 32.5x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy MASI stock?
MASI appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $187.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do MASI price targets vary so much?
MASI analyst price targets range from $180 to $200, a 11% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $187.5 consensus represents the middle ground.